Evidence map›Paper›PMID 37205399›Full record

ArticleResearch square2023

Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital Fistula Repair: Protocol for a Mixed-Methods Study in Uganda.

Alison M El Ayadi, Susan Obore, Fred Kirya, Suellen Miller, Abner Korn, Hadija Nalubwama, John Neuhaus, Monica Getahun, Patrick Eyul, Robert Twine and 2 more

Registry-linked trialOpen access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05437939 (Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05437939 active not recruitingnot on this map

Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital

TypeobservationalSponsorUniversity of California, San FranciscoRan2022 to 2026Enrolled802ConditionsFemale Genital Fistula, Incontinence
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Alison M El AyadiUniversity of California, San Francisco.
Susan OboreMulago Specialized Women and Neonatal Hospital.
Fred KiryaSoroti University.
Suellen MillerUniversity of California, San Francisco.
Abner KornUniversity of California, San Francisco.
Hadija NalubwamaMakerere University.
John NeuhausUniversity of California, San Francisco.
Monica GetahunUniversity of California, San Francisco.
Patrick EyulInfectious Disease Research Collaboration.
Robert TwineInfectious Disease Research Collaboration.
Erin V W AndrewThomas Jefferson University.
Justus K BarageineMakerere University.
University of California, San Francisco · USInfectious Diseases Research Collaboration · UGMakerere University · UGSoroti University · UGThomas Jefferson University · US

Funding

Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital Fistula RepairR01HD101570 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EL AYADI, ALISON M · 2021 to 2025
$3.1M
NICHD NIH HHS R01 HD101570
6 · The paper itself

Abstract

Background: Female genital fistula is a traumatic debilitating injury, frequently caused by prolonged obstructed labor, affecting between 500,000-2 million women in lower-resource settings. Vesicovaginal fistula causes urinary incontinence. Other gynecologic, neurologic and orthopedic morbidity may occur during fistula development. Women with fistula are stigmatized; limit engagement in social, economic, or religious activities; and report high psychiatric morbidity. Improved global surgical access has reduced fistula consequences yet post-repair risks impacting quality of life and well-being include fistula repair breakdown or recurrence and ongoing or changing urine leakage or incontinence. Limited evidence on risk factors contributing to adverse outcomes hinders interventions to mitigate adverse events, protecting health and quality of life after surgery. This study seeks to identify predictors and characteristics of post-repair fistula breakdown and recurrence (Aim 1) and post-repair incontinence (Aim 2), and to identify feasible and acceptable intervention strategies (Aim 3). Methods: This mixed-methods study incorporates a prospective cohort study of women with successful vesicovaginal fistula repair at approximately 12 fistula repair centers and affiliated care sites in Uganda (Aims 1-2) followed by qualitative inquiry among key stakeholders (Aim 3). Cohort participants will have a baseline visit at the time of surgery followed by data collection at 2 weeks, 6 weeks, 3 months and quarterly thereafter for 3 years. Primary predictors to be evaluated include patient-related factors, fistula-related factors, fistula repair-related factors, and post-repair behaviors and exposures, collected via structured questionnaire at all data collection points. Clinical exams will be conducted at baseline, 2 weeks post-surgery, and for outcome confirmation at symptom development. Primary outcomes are fistula repair breakdown or fistula recurrence and post-repair incontinence. In-depth interviews will be conducted with cohort participants (n ~ 40) and other key stakeholders (~ 40 including family, peers, community members and clinical/social service providers) to develop feasible and acceptable intervention concepts for adjustment of identified risk factors. Discussion: Participant recruitment is underway. This study is expected to identify key predictors that can directly improve fistula repair and post-repair programs and women's outcomes, optimizing health and quality of life. Furthermore, our study will create a comprehensive longitudinal dataset capable of supporting broad inquiry into post-fistula repair health. Trial Registration: ClinicalTrials.gov Identifier: NCT05437939.

Indexed as

Female genital fistulafistula repairmixed-methodsobstructed laborpost-repair incontinencereconstructive surgeryrecurrencereintegrationstillbirthvesicovaginal fistula

Identifiers

PMID37205399
PMCPMC10187434
OpenAlexW4372341822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.